These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31999329)

  • 1. Coronary microvascular dysfunction in hypertrophy and heart failure.
    Camici PG; Tschöpe C; Di Carli MF; Rimoldi O; Van Linthout S
    Cardiovasc Res; 2020 Mar; 116(4):806-816. PubMed ID: 31999329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
    Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Hypertrophy Is Associated With Increased Infarct Size and Decreased Myocardial Salvage in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Nepper-Christensen L; Lønborg J; Ahtarovski KA; Høfsten DE; Kyhl K; Ghotbi AA; Schoos MM; Göransson C; Bertelsen L; Køber L; Helqvist S; Pedersen F; Saünamaki K; Jørgensen E; Kelbæk H; Holmvang L; Vejlstrup N; Engstrøm T
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28069574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary microvascular dysfunction: a key step in the development of uraemic cardiomyopathy?
    Radhakrishnan A; Pickup LC; Price AM; Law JP; Edwards NC; Steeds RP; Ferro CJ; Townend JN
    Heart; 2019 Sep; 105(17):1302-1309. PubMed ID: 31239278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction.
    Katz DH; Beussink L; Sauer AJ; Freed BH; Burke MA; Shah SJ
    Am J Cardiol; 2013 Oct; 112(8):1158-64. PubMed ID: 23810323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Left Ventricular Hypertrophy to Dysfunction and Failure.
    Lazzeroni D; Rimoldi O; Camici PG
    Circ J; 2016; 80(3):555-64. PubMed ID: 26853555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
    Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
    Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial contraction fraction derived from cardiovascular magnetic resonance cine images-reference values and performance in patients with heart failure and left ventricular hypertrophy.
    Arenja N; Fritz T; Andre F; Riffel JH; Aus dem Siepen F; Ochs M; Paffhausen J; Hegenbart U; Schönland S; Müller-Hennessen M; Giannitsis E; Kristen AV; Katus HA; Friedrich MG; Buss SJ
    Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1414-1422. PubMed ID: 28165128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of systolic and diastolic properties of hypertensive heart failure using speckle-tracking echocardiography with high volume rates.
    Minatoguchi S; Kawasaki M; Tanaka R; Yoshizane T; Ono K; Saeki M; Nagaya M; Sato H; Nishigaki K; Noda T; Zile MR; Minatoguchi S
    Heart Vessels; 2017 Oct; 32(10):1202-1213. PubMed ID: 28638961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.
    Heinzel FR; Hohendanner F; Jin G; Sedej S; Edelmann F
    J Appl Physiol (1985); 2015 Nov; 119(10):1233-42. PubMed ID: 26183480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensatory remodeling of coronary microvasculature maintains shear stress in porcine left-ventricular hypertrophy.
    Huo Y; Kassab GS
    J Hypertens; 2012 Mar; 30(3):608-16. PubMed ID: 22252479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary microvascular function is independently associated with left ventricular filling pressure in patients with type 2 diabetes mellitus.
    Kawata T; Daimon M; Miyazaki S; Ichikawa R; Maruyama M; Chiang SJ; Ito C; Sato F; Watada H; Daida H
    Cardiovasc Diabetol; 2015 Aug; 14():98. PubMed ID: 26242308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The coronary circulation and blood flow in left ventricular hypertrophy.
    Camici PG; Olivotto I; Rimoldi OE
    J Mol Cell Cardiol; 2012 Apr; 52(4):857-64. PubMed ID: 21924273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction.
    Tromp J; Lim SL; Tay WT; Teng TK; Chandramouli C; Ouwerkerk W; Wander GS; Sawhney JPS; Yap J; MacDonald MR; Ling LH; Sattar N; McMurray JJV; Richards AM; Anand I; Lam CSP;
    Diabetes Care; 2019 Sep; 42(9):1792-1799. PubMed ID: 31292141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial reverse remodeling: how far can we rewind?
    Rodrigues PG; Leite-Moreira AF; Falcão-Pires I
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1402-22. PubMed ID: 26993225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.